[Hazards in the management of cardiogenic shock using vasopressore].
D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006982:Hypertonic Solutions; D008680:Metaraminol / Q000009:adverse effects; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D009638:Norepinephrine / Q000009:adverse effects; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
D006982:Hypertonic Solutions; D014662:Vasoconstrictor Agents; D008680:Metaraminol; D009638:Norepinephrine
Das Risiko der Behandlung des Schocks des Herzinfarktes mittels Vasopressoren.